1. Home
  2. LEGN vs BBWI Comparison

LEGN vs BBWI Comparison

Compare LEGN & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • BBWI
  • Stock Information
  • Founded
  • LEGN 2014
  • BBWI 1963
  • Country
  • LEGN United States
  • BBWI United States
  • Employees
  • LEGN N/A
  • BBWI N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • BBWI Clothing/Shoe/Accessory Stores
  • Sector
  • LEGN Health Care
  • BBWI Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • BBWI Nasdaq
  • Market Cap
  • LEGN 7.0B
  • BBWI 8.2B
  • IPO Year
  • LEGN 2020
  • BBWI N/A
  • Fundamental
  • Price
  • LEGN $39.70
  • BBWI $38.58
  • Analyst Decision
  • LEGN Strong Buy
  • BBWI Buy
  • Analyst Count
  • LEGN 12
  • BBWI 18
  • Target Price
  • LEGN $79.50
  • BBWI $43.59
  • AVG Volume (30 Days)
  • LEGN 976.3K
  • BBWI 3.4M
  • Earning Date
  • LEGN 03-10-2025
  • BBWI 02-27-2025
  • Dividend Yield
  • LEGN N/A
  • BBWI 2.07%
  • EPS Growth
  • LEGN N/A
  • BBWI 28.69
  • EPS
  • LEGN N/A
  • BBWI 4.12
  • Revenue
  • LEGN $520,183,000.00
  • BBWI $7,432,000,000.00
  • Revenue This Year
  • LEGN $121.13
  • BBWI $0.17
  • Revenue Next Year
  • LEGN $65.25
  • BBWI $2.79
  • P/E Ratio
  • LEGN N/A
  • BBWI $9.37
  • Revenue Growth
  • LEGN 122.96
  • BBWI 0.36
  • 52 Week Low
  • LEGN $30.17
  • BBWI $26.21
  • 52 Week High
  • LEGN $70.13
  • BBWI $52.99
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 64.82
  • BBWI 54.73
  • Support Level
  • LEGN $34.36
  • BBWI $34.65
  • Resistance Level
  • LEGN $36.39
  • BBWI $40.46
  • Average True Range (ATR)
  • LEGN 1.67
  • BBWI 1.38
  • MACD
  • LEGN 0.34
  • BBWI 0.29
  • Stochastic Oscillator
  • LEGN 94.68
  • BBWI 65.39

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2023. For fiscal 2023, 74% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2022 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.

Share on Social Networks: